These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 25399640)

  • 1. Catalytic mechanisms and regulation of protein kinases.
    Wang Z; Cole PA
    Methods Enzymol; 2014; 548():1-21. PubMed ID: 25399640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A structural atlas of kinases inhibited by clinically approved drugs.
    Wang Q; Zorn JA; Kuriyan J
    Methods Enzymol; 2014; 548():23-67. PubMed ID: 25399641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase structure and function analysis with chemical tools.
    Shen K; Hines AC; Schwarzer D; Pickin KA; Cole PA
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):65-78. PubMed ID: 16213197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The logic and design of analog-sensitive kinases and their small molecule inhibitors.
    Lopez MS; Kliegman JI; Shokat KM
    Methods Enzymol; 2014; 548():189-213. PubMed ID: 25399647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited Proteolysis Combined with Stable Isotope Labeling Reveals Conformational Changes in Protein (Pseudo)kinases upon Binding Small Molecules.
    Di Michele M; Stes E; Vandermarliere E; Arora R; Astorga-Wells J; Vandenbussche J; van Heerde E; Zubarev R; Bonnet P; Linders JT; Jacoby E; Brehmer D; Martens L; Gevaert K
    J Proteome Res; 2015 Oct; 14(10):4179-93. PubMed ID: 26293246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for the identification of kinase substrates using analog-sensitive kinases.
    Koch A; Hauf S
    Eur J Cell Biol; 2010; 89(2-3):184-93. PubMed ID: 20061049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolution of protein kinase inhibitors from antagonists to agonists of cellular signaling.
    Dar AC; Shokat KM
    Annu Rev Biochem; 2011; 80():769-95. PubMed ID: 21548788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The resistance tetrad: amino acid hotspots for kinome-wide exploitation of drug-resistant protein kinase alleles.
    Bailey FP; Andreev VI; Eyers PA
    Methods Enzymol; 2014; 548():117-46. PubMed ID: 25399644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical approaches towards unravelling kinase-mediated signalling pathways.
    Hodgson DR; Schröder M
    Chem Soc Rev; 2011 Mar; 40(3):1211-23. PubMed ID: 21152652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, validation and efficacy of bisubstrate inhibitors specifically affecting ecto-CK2 kinase activity.
    Cozza G; Zanin S; Sarno S; Costa E; Girardi C; Ribaudo G; Salvi M; Zagotto G; Ruzzene M; Pinna LA
    Biochem J; 2015 Nov; 471(3):415-30. PubMed ID: 26349539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteus in the world of proteins: conformational changes in protein kinases.
    Rabiller M; Getlik M; Klüter S; Richters A; Tückmantel S; Simard JR; Rauh D
    Arch Pharm (Weinheim); 2010 Apr; 343(4):193-206. PubMed ID: 20336692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase biochemistry and drug discovery.
    Schwartz PA; Murray BW
    Bioorg Chem; 2011 Dec; 39(5-6):192-210. PubMed ID: 21872901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the roles of protein kinases using chemical genetics.
    Elphick LM; Lee SE; Anderson AA; Child ES; Bonnac L; Gouverneur V; Mann DJ
    Future Med Chem; 2009 Oct; 1(7):1233-41. PubMed ID: 21426100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisubstrate inhibitors of protein kinases: from principle to practical applications.
    Lavogina D; Enkvist E; Uri A
    ChemMedChem; 2010 Jan; 5(1):23-34. PubMed ID: 19774589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolutionary variation and adaptation in a conserved protein kinase allosteric network: implications for inhibitor design.
    Oruganty K; Kannan N
    Biochim Biophys Acta; 2013 Jul; 1834(7):1322-9. PubMed ID: 23499783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical proteomics and functional proteomics strategies for protein kinase inhibitor validation and protein kinase substrate identification: applications to protein kinase CK2.
    Gyenis L; Turowec JP; Bretner M; Litchfield DW
    Biochim Biophys Acta; 2013 Jul; 1834(7):1352-8. PubMed ID: 23416530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bivalent inhibitors of protein kinases.
    Gower CM; Chang ME; Maly DJ
    Crit Rev Biochem Mol Biol; 2014; 49(2):102-15. PubMed ID: 24564382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for the NMR-based identification and optimization of allosteric protein kinase inhibitors.
    Jahnke W; Blommers MJ; Fernández C; Zwingelstein C; Amstutz R
    Chembiochem; 2005 Sep; 6(9):1607-10. PubMed ID: 16028302
    [No Abstract]   [Full Text] [Related]  

  • 19. A new paradigm for protein kinase inhibition: blocking phosphorylation without directly targeting ATP binding.
    Bogoyevitch MA; Fairlie DP
    Drug Discov Today; 2007 Aug; 12(15-16):622-33. PubMed ID: 17706543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exquisitely specific bisubstrate inhibitors of c-Src kinase.
    Brandvold KR; Santos SM; Breen ME; Lachacz EJ; Steffey ME; Soellner MB
    ACS Chem Biol; 2015 Jun; 10(6):1387-91. PubMed ID: 25793938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.